(firstQuint)Treatment of Nodular Basal Cell Carcinoma (BCC) With Imiquimod 5% Cream After Curettage.

 The primary objective of this study is to evaluate the efficacy of imiquimod 5% cream on nodular BCC lesions treated 5x/week for 6 weeks after primary treatment with curettage without electrodesiccation.

 The secondary objective of this study is to evaluate the cosmetic outcome after treatment of the lesions using this modality.

.

 Treatment of Nodular Basal Cell Carcinoma (BCC) With Imiquimod 5% Cream After Curettage@highlight

To assess the efficacy of treating a nodular basal cell carcinoma with imiquimod cream after initial treatment with curettage